CDRH Updates: Information on Premarket Approval Applications: TAXUS(R) Liberté(R) Atom(TM) Paclitaxel-Eluting Coronary Stent System

June 4, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

FDA -- Information on Premarket Approval Applications for TAXUS® Liberté® Atom™ Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire Delivery Systems) - P060008/S008.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Food and Drug Administration (FDA)